FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kenichi Yasunari

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Disorders

Physiology

Cell Movement

Co-author Network

Publications

TOP 3
Kenichi Yasunari
[Low renin hypertension].
Kenichi Yasunari; Tokuzo Matsui; Kensaku Maeda; Munehiro Nakamura; Takanori Watanabe; Nobuo Kiriike
Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension.
Takanori Watanabe; Kenichi Yasunari; Munehoro Nakamura
Antioxidative actions of statins: potential mechanisms for antiathersclerotic effects.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kenichi Yasunari (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Kenichi Yasunari
[Low renin hypertension].
Nihon rinsho. Japanese journal of clinical medicine 2006;Suppl 3():520-2.
2006: Kenichi Yasunari; Tokuzo Matsui; Kensaku Maeda; Munehiro Nakamura; Takanori Watanabe; Nobuo Kiriike
Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension.
American journal of hypertension 2006;19(6):573-8.
2006: Takanori Watanabe; Kenichi Yasunari; Munehoro Nakamura
Antioxidative actions of statins: potential mechanisms for antiathersclerotic effects.
Mini reviews in medicinal chemistry 2006;6(5):505-8.
2006: T Watanabe; Kenichi Yasunari; M Nakamura; K Maeda
Carotid artery intima-media thickness and reactive oxygen species formation by monocytes in hypertensive patients.
Journal of human hypertension 2006;20(5):336-40.
2006: Kenichi Yasunari; Takanori Watanabe; Munehiro Nakamura
Reactive oxygen species formation by polymorphonuclear cells and mononuclear cells as a risk factor of cardiovascular diseases.
Current pharmaceutical biotechnology 2006;7(2):73-80.
2006: Shinichiro Ueda; Kenichi Yasunari
What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin? Focus on vitamin E and cardiovascular disease.
Current pharmaceutical biotechnology 2006;7(2):69-72.
2005: Kensaku Maeda; Kenichi Yasunari; Takanori Watanabe; Munehiro Nakamura
Oxidative stress by peripheral blood mononuclear cells is increased in hypertensives with an extreme-dipper pattern and/or morning surge in blood pressure.
Hypertension research : official journal of the Japanese Society of Hypertension 2005;28(9):755-61.
2005: Kensaku Maeda; Kenichi Yasunari; Eisuke F Sato; Masayasu Inoue
Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig.
Atherosclerosis 2005;181(1):87-92.
2005: Kenichi Yasunari; Kensaku Maeda; Munehiro Nakamura; Takanori Watanabe; Junichi Yoshikawa
Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension.
Hypertension research : official journal of the Japanese Society of Hypertension 2005;28(2):107-12.
2005: Kenichi Yasunari; K Maeda; M Nakamura; T Watanabe; J Yoshikawa; K Hirohashi
Left ventricular hypertrophy and angiotensin II receptor blocking agents.
Current medicinal chemistry. Cardiovascular and hematological agents 2005;3(1):61-7.
2004: Kenichi Yasunari; Kensaku Maeda; Takanori Watanabe; Munehiro Nakamura; Junichi Yoshikawa; Akira Asada
Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy.
Journal of the American College of Cardiology 2004;43(11):2116-23.
2004: Kenichi Yasunari; Kensaku Maeda; Munehiro Nakamura; Takanori Watanabe; Junichi Yoshikawa; Akira Asada
Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension.
The American journal of medicine 2004;116(7):460-5.
2004: Kenichi Yasunari; Kensaku Maeda; Munehiro Nakamura; Takanori Watanabe; Junichi Yoshikawa; Akira Asada
Pharmacological and clinical studies with temocapril, an angiotensin converting enzyme inhibitor that is excreted in the bile.
Cardiovascular drug reviews 2004;22(3):189-98.
2003: Kenichi Yasunari; Kensaku Maeda; Takanori Watanabe; Munehiro Nakamura; Akira Asada; Junichi Yoshikawa
Converting enzyme inhibitor temocaprilat prevents high glucose-mediated suppression of human aortic endothelial cell proliferation.
Journal of cardiovascular pharmacology 2003;42 Suppl 1():S55-60.
2003: Kensaku Maeda; Kenichi Yasunari; Eisuke F Sato; Junichi Yoshikawa; Masayasu Inoue
Activation of protein kinase C and nicotinamide adenine dinucleotide phosphate oxidase in leukocytes of spontaneously hypertensive rats.
Hypertension research : official journal of the Japanese Society of Hypertension 2003;26(12):999-1006.
2003: Kenichi Yasunari; Kensaku Maeda; Munehiro Nakamura; Junichi Yoshikawa
Dopamine as a novel anti-migration factor of vascular smooth muscle cells through D1A and D1B receptors.
Journal of cardiovascular pharmacology 2003;41 Suppl 1():S33-8.
2002: Kenichi Yasunari; Kensaku Maeda; Munehiro Nakamura; Junichi Yoshikawa
Carvedilol inhibits pressure-induced increase in oxidative stress in coronary smooth muscle cells.
Hypertension research : official journal of the Japanese Society of Hypertension 2002;25(3):419-25.
2002: Kenichi Yasunari; Kensaku Maeda; Munehiro Nakamura; Junichi Yoshikawa
Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein.
Hypertension 2002;39(3):777-80.
2002: Kenichi Yasunari; Kensaku Maeda; Munehiro Nakamura; Junichi Yoshikawa
Pressure promotes angiotensin II--mediated migration of human coronary smooth muscle cells through increase in oxidative stress.
Hypertension 2002;39(2 Pt 2):433-7.
2001: Kenichi Yasunari; Kensaku Maeda; M Minami; Junichi Yoshikawa
HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(6):937-42.
2000: M Kohno; M Minami; H Kano; Kenichi Yasunari; K Maeda; T Hanehira; Junichi Yoshikawa
Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left venticular hypertrophy.
Metabolism: clinical and experimental 2000;49(10):1356-60.
2000: Kenichi Yasunari; M Kohno; H Kano; M Minami; Junichi Yoshikawa
Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors.
Circulation 2000;101(19):2302-8.
2000: M Kohno; Kenichi Yasunari; M Minami; H Kano; K Maeda; Junichi Yoshikawa
Suppression by eicosapentaenoic acid of oxidized low-density lipoprotein and lysophosphatidylcholine-induced migration in cultured rat vascular smooth muscle cells.
Metabolism: clinical and experimental 2000;49(5):560-2.
2000: Kenichi Yasunari; M Kohno; H Kano; M Minami; Junichi Yoshikawa
Aldose reductase inhibitor improves insulin-mediated glucose uptake and prevents migration of human coronary artery smooth muscle cells induced by high glucose.
Hypertension 2000;35(5):1092-8.
2000: M Kohno; Kenichi Yasunari; K Maeda; H Kano; M Minami; T Hanehira; Junichi Yoshikawa
Effects of cardiac natriuretic peptides on oxidized low-density lipoprotein- and lysophosphatidylcholine-induced human mesangial cell migration.
Hypertension 2000;35(4):971-7.
2000: Kenichi Yasunari; M Kohno; M Minami; H Kano; M Ohhira; Kenji Nakamura; Junichi Yoshikawa
A dopamine-secreting pheochromocytoma.
Journal of cardiovascular pharmacology 2000;36 Suppl 2():S75-7.
1999: M Kohno; Kenichi Yasunari; M Minami; H Kano; K Maeda; A K Mandal; Ken Inoki; M Haneda; Junichi Yoshikawa
Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin.
Journal of the American Society of Nephrology : JASN 1999;10(12):2495-502.
1999: M Kohno; K Yokokawa; M Minami; Kenichi Yasunari; K Maeda; H Kano; T Hanehira; Junichi Yoshikawa
Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension.
Metabolism: clinical and experimental 1999;48(10):1256-9.
1999: Kenichi Yasunari; M Kohno; Junichi Yoshikawa
[Pathophysiology of vascular complications in diabetes].
Nihon rinsho. Japanese journal of clinical medicine 1999;57(7):1642-7.
1999: M Kohno; K Yokokawa; M Minami; H Kano; Kenichi Yasunari; T Hanehira; Junichi Yoshikawa
Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
The American journal of medicine 1999;106(5):544-9.
1999: Kenichi Yasunari; M Kohno; H Kano; T Hanehira; M Minami; Junichi Yoshikawa
Anti-atherosclerotic action of vascular D1 receptors.
Clinical and experimental pharmacology & physiology. Supplement 1999;26():S36-40.
1999: Kenichi Yasunari; M Kohno; H Kano; K Yokokawa; M Minami; Junichi Yoshikawa
Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose.
Circulation 1999;99(10):1370-8.
1998: M Kohno; K Yokokawa; Kenichi Yasunari; M Minami; H Kano; A K Mandal; Junichi Yoshikawa
Heparin inhibits human coronary artery smooth muscle cell migration.
Metabolism: clinical and experimental 1998;47(9):1065-9.
1998: M Kohno; K Yokokawa; Kenichi Yasunari; M Minami; H Kano; T Hanehira; Junichi Yoshikawa
Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration.
Circulation 1998;98(4):353-9.
1998: M Minami; K Yokokawa; M Kohno; Kenichi Yasunari; Junichi Yoshikawa
Suppression of endothelin-3-induced nitric oxide synthesis by triglyceride in human endothelial cells.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S467-9.
1998: K Yokokawa; M Kohno; M Minami; Kenichi Yasunari; A K Mandal; Junichi Yoshikawa
Heparin suppresses cyclosporine-induced endothelin-1 synthesis in rat endothelial cells.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S460-3.
1998: M Kohno; K Yokokawa; Kenichi Yasunari; H Kano; M Minami; Junichi Yoshikawa
Effect of the endothelin family of peptides on human coronary artery smooth-muscle cell migration.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S84-9.
1997: Kenichi Yasunari; M Kohno; H Kano; K Yokokawa; M Minami; Junichi Yoshikawa
Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells.
Circulation research 1997;81(6):953-62.
1997: Kenichi Yasunari; M Kohno; Tadayoshi Hasuma; T Horio; H Kano; K Yokokawa; M Minami; Junichi Yoshikawa
Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):3164-73.
1997: M Kohno; K Yokokawa; Kenichi Yasunari; H Kano; M Minami; Makiko Ueda; Junichi Yoshikawa
Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells.
Circulation research 1997;81(4):585-90.
1997: M Kohno; K Yokokawa; Kenichi Yasunari; H Kano; M Minami; Makiko Ueda; Y Tatsumi; Junichi Yoshikawa
Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
Metabolism: clinical and experimental 1997;46(9):1032-8.
1997: M Kohno; K Yokokawa; H Kano; Kenichi Yasunari; M Minami; T Hanehira; Junichi Yoshikawa
Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells.
Hypertension 1997;29(6):1309-13.
1997: M Ikeda; M Kohno; Kenichi Yasunari; K Yokokawa; T Horio; Makiko Ueda; N Morisaki; Junichi Yoshikawa
Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(4):731-6.
1997: M Kohno; K Murakawa; Kenichi Yasunari; K Yokokawa; T Horio; H Kano; M Minami; Junichi Yoshikawa
Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients.
Metabolism: clinical and experimental 1997;46(3):287-91.
1997: Kenichi Yasunari; M Kohno; H Kano; K Yokokawa; M Minami; Junichi Yoshikawa
Vascular dopamine-I receptors and atherosclerosis.
Journal of atherosclerosis and thrombosis 1997;4(2):59-64.
1997: Kenichi Yasunari; M Kohno; H Kano; K Yokokawa; M Minami; Junichi Yoshikawa
Dopamine D1-like receptor stimulation inhibits hypertrophy induced by platelet-derived growth factor in cultured rat renal vascular smooth muscle cells.
Hypertension 1997;29(1 Pt 2):350-5.
1997: M Kohno; K Yokokawa; Kenichi Yasunari; H Kano; M Minami; T Hanehira; Junichi Yoshikawa
Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
International journal of clinical pharmacology and therapeutics 1997;35(1):38-42.
1996: M Kohno; Kenichi Yasunari; K Yokokawa; T Horio; H Kano; M Minami; M Ikeda; J Yoshikawa
Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy.
Metabolism: clinical and experimental 1996;45(11):1326-9.
1996: Kenichi Yasunari; M Kohno; H Kano; K Yokokawa; T Horio; J Yoshikawa
Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration.
Hypertension 1996;28(2):159-68.
1996: M Kohno; Kenichi Yasunari; K Yokokawa; T Horio; M Ikeda; H Kano; M Minami; T Hanehira; J Yoskikawa
Interaction of adrenomedullin and platelet-derived growth factor on rat mesangial cell production of endothelin.
Hypertension 1996;27(3 Pt 2):663-7.
1996: H Kano; M Kohno; Kenichi Yasunari; K Yokokawa; T Horio; M Ikeda; M Minami; T Hanehira; Tadashi Takeda; J Yoshikawa
Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells.
Journal of hypertension 1996;14(2):209-13.
1996: M Kohno; T Hanehira; H Kano; T Horio; K Yokokawa; M Ikeda; M Minami; Kenichi Yasunari; J Yoshikawa
Plasma adrenomedullin concentrations in essential hypertension.
Hypertension 1996;27(1):102-7.
1995: M Ikeda; M Kohno; T Horio; Kenichi Yasunari; K Yokokawa; H Kano; M Minami; T Hanehira; T Fukui; Tadashi Takeda
Effect of thrombin and PDGF on endothelin production in cultured mesangial cells derived from spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology. Supplement 1995;22(1):S197-8.
1995: K Yokokawa; M Kohno; M Minami; M Ikeda; T Horio; H Kano; T Hanehira; Kenichi Yasunari; Tadashi Takeda
Enhanced phosphoinositide turnover signalling stimulated by endothelin B-type receptor in endothelial cells from spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology. Supplement 1995;22(1):S195-6.
1995: Kenichi Yasunari; M Kohno; H Kano; T Hanehira; M Minami; M Ikeda; T Horio; K Yokokawa; Tadashi Takeda
Elevated glucose concentration and natriuretic peptides receptor response on vascular smooth muscle of spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology. Supplement 1995;22(1):S180-2.
1995: M Minami; K Yokokawa; M Kohno; M Ikeda; T Horio; H Kano; T Hanehira; Kenichi Yasunari; Tadashi Takeda
Promotion of nitric oxide formation by heparin in cultured aortic endothelial cells from spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology. Supplement 1995;22(1):S146-7.
1995: M Minami; K Yokokawa; M Kohno; M Ikeda; T Horio; H Kano; T Hanehira; Kenichi Yasunari; Tadashi Takeda
Promotion of nitric oxide formation by heparin in cultured aortic endothelial cells from spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology 1995;22 Suppl 1():S146-7.
1995: Kenichi Yasunari; M Kohno; H Kano; K Yokokawa; T Horio; J Yoshikawa
Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(12):2207-12.
1995: T Horio; M Kohno; H Kano; M Ikeda; Kenichi Yasunari; K Yokokawa; M Minami; Tadashi Takeda
Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells.
Circulation research 1995;77(4):660-4.
1995: K Yokokawa; R Mankus; M G Saklayen; M Kohno; Kenichi Yasunari; M Minami; H Kano; T Horio; Tadashi Takeda; A K Mandel
Increased nitric oxide production in patients with hypotension during hemodialysis.
Annals of internal medicine 1995;123(1):35-7.
1995: Kenichi Yasunari; M Kohno; K Yokokawa; T Horio; H Kano; Tadashi Takeda
Vascular dopamine-I receptors.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18 Suppl 1():S29-33.
1995: M Kohno; H Kano; T Horio; K Yokokawa; Kenichi Yasunari; Tadashi Takeda
Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells.
Hypertension 1995;25(6):1185-90.
1995: M Kohno; K Yokokawa; A K Mandal; T Horio; Kenichi Yasunari; Tadashi Takeda
Cardiac natriuretic peptides inhibit cyclosporine-induced production of endothelin in cultured rat mesangial cells.
Metabolism: clinical and experimental 1995;44(3):404-9.
1995: M Kohno; T Horio; K Yokokawa; Kenichi Yasunari; M Ikeda; M Minami; N Kurihara; Tadashi Takeda
Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
The American journal of medicine 1995;98(3):257-65.
1995: M Kohno; K Yokokawa; Kenichi Yasunari; H Kano; T Horio; Tadashi Takeda
Stimulation of cyclic adenosine monophosphate formation by the novel vasorelaxant peptide adrenomedullin in cultured rat mesangial cells.
Metabolism: clinical and experimental 1995;44(1):10-2.
1994: K Yokokawa; J Johnson; M Kohno; A K Mandal; M Yanagisawa; T Horio; Kenichi Yasunari; Tadashi Takeda
Phosphoinositide turnover signaling stimulated by ET-3 in endothelial cells from spontaneously hypertensive rats.
The American journal of physiology 1994;267(3 Pt 2):R635-44.
1994: Kenichi Yasunari; M Kohno; K Yokokawa; T Horio; Tadashi Takeda
Dopamine DA1 receptors on vascular smooth muscle cells are regulated by glucocorticoid and sodium chloride.
The American journal of physiology 1994;267(3 Pt 2):R628-34.
1994: M Kohno; T Horio; K Yokokawa; Kenichi Yasunari; N Kurihara; Tadashi Takeda
Endothelin modulates the mitogenic effect of PDGF on glomerular mesangial cells.
The American journal of physiology 1994;266(6 Pt 2):F894-900.
1994: T Horio; M Kohno; Kenichi Yasunari; K Murakawa; K Yokokawa; M Ikeda; T Fukui; H Kano; Tadashi Takeda
Relationship between the regression of left ventricular hypertrophy and the changes in circadian blood pressure after long-term treatment with enalapril in hypertensive patients.
International journal of clinical pharmacology and therapeutics 1994;32(4):177-82.
1994: M Kohno; T Fukui; T Horio; K Yokokawa; Kenichi Yasunari; Minoru Yoshiyama; N Kurihara; Tadashi Takeda
Cardiac hypertrophy and brain natriuretic peptide in experimental hypertension.
The American journal of physiology 1994;266(2 Pt 2):R451-7.
1993: M Kohno; M Ikeda; M Johchi; T Horio; Kenichi Yasunari; N Kurihara; Tadashi Takeda
Interaction of PDGF and natriuretic peptides on mesangial cell proliferation and endothelin secretion.
The American journal of physiology 1993;265(5 Pt 1):E673-9.
1993: M Kohno; T Horio; Kenichi Yasunari; K Yokokawa; M Ikeda; N Kurihara; Yoshiki Nishizawa; Hirotoshi Morii; Tadashi Takeda
Stimulation of brain natriuretic peptide release from the heart by thyroid hormone.
Metabolism: clinical and experimental 1993;42(8):1059-64.
1993: T Horio; M Kohno; Kenichi Yasunari; K Murakawa; K Yokokawa; M Ikeda; T Fukui; Tadashi Takeda
Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells.
Atherosclerosis 1993;101(2):185-90.
1993: M Kohno; T Horio; M Ikeda; K Yokokawa; T Fukui; Kenichi Yasunari; K Murakawa; N Kurihara; Tadashi Takeda
Natriuretic peptides inhibit mesangial cell production of endothelin induced by arginine vasopressin.
The American journal of physiology 1993;264(4 Pt 2):F678-83.
1993: Kenichi Yasunari; M Kohno; K Murakawa; K Yokokawa; T Horio; Tadashi Takeda
Interaction between a phorbol ester and dopamine DA1 receptors on vascular smooth muscle.
The American journal of physiology 1993;264(1 Pt 2):F24-30.
1993: K Yokokawa; M Kohno; M Johchi; T Horio; K Murakawa; Kenichi Yasunari; M Yanagisawa; Tadashi Takeda
Effect of endothelin receptor antagonist, BQ-123, on Ca2+ signaling in cultured rat mesangial cells.
Life sciences 1993;53(21):1631-41.
1993: K Yokokawa; M Kohno; H Tahara; A K Mandal; Kenichi Yasunari; K Murakawa; T Horio; M Ikeda; M Minami; Tadashi Takeda
Effect of heparin on endothelin-1 production by cultured human endothelial cells.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S46-8.
1992: K Yokokawa; A K Mandal; M Kohno; T Horio; K Murakawa; Kenichi Yasunari; Tadashi Takeda
Heparin suppresses endothelin-1 action and production in spontaneously hypertensive rats.
The American journal of physiology 1992;263(5 Pt 2):R1035-41.
1992: M Kohno; T Horio; M Ikeda; K Yokokawa; T Fukui; Kenichi Yasunari; N Kurihara; Tadashi Takeda
Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells.
Kidney international 1992;42(4):860-6.
1992: Kenichi Yasunari; M Kohno; K Murakawa; K Yokokawa; T Horio; Tadashi Takeda
Phorbol ester and atrial natriuretic peptide receptor response on vascular smooth muscle.
Hypertension 1992;19(4):314-9.
1992: M Kohno; K Yokokawa; T Horio; Kenichi Yasunari; K Murakawa; M Ikeda; Tadashi Takeda
Release mechanism of endothelin-1 and big endothelin-1 after stimulation with thrombin in cultured porcine endothelial cells.
Journal of vascular research 1992;29(2):56-63.
1992: M Kohno; T Horio; K Yokokawa; K Murakawa; Kenichi Yasunari; N Kurihara; Tadashi Takeda
Atrial and brain natriuretic peptides: secretion during exercise in patients with essential hypertension and modulation by acute angiotensin-converting enzyme inhibition.
Clinical and experimental pharmacology & physiology 1992;19(3):193-200.
1992: M Kohno; K Yokokawa; T Horio; Kenichi Yasunari; K Murakawa; Tadashi Takeda
Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta.
Circulation research 1992;70(2):241-7.
1992: M Kohno; T Horio; K Yokokawa; K Murakawa; Kenichi Yasunari; Kaname Akioka; A Tahara; I Toda; Kazuhide Takeuchi; N Kurihara
Brain natriuretic peptide as a cardiac hormone in essential hypertension.
The American journal of medicine 1992;92(1):29-34.
1991: T Horio; M Kohno; K Yokokawa; K Murakawa; Kenichi Yasunari; H Fujiwara; N Kurihara; Tadashi Takeda
Effect of hypoxia on plasma immunoreactive endothelin-1 concentration in anesthetized rats.
Metabolism: clinical and experimental 1991;40(10):999-1001.
1991: K Yokokawa; M Kohno; Kenichi Yasunari; K Murakawa; Tadashi Takeda
Endothelin-3 regulates endothelin-1 production in cultured human endothelial cells.
Hypertension 1991;18(3):304-15.
1991: T Horio; M Kohno; K Murakawa; Kenichi Yasunari; K Yokokawa; M Ueda; Tadashi Takeda
Increased plasma immunoreactive endothelin-1 concentration in hypercholesterolemic rats.
Atherosclerosis 1991;89(2-3):239-46.
1991: M Kohno; K Murakawa; T Horio; K Yokokawa; Kenichi Yasunari; T Fukui; Tadashi Takeda
Plasma immunoreactive endothelin-1 in experimental malignant hypertension.
Hypertension 1991;18(1):93-100.
1991: M Kohno; Kenichi Yasunari; K Yokokawa; K Murakawa; T Horio; Tadashi Takeda
Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells.
The Journal of clinical investigation 1991;87(6):1999-2004.
1991: K Yokokawa; H Tahara; M Kohno; K Murakawa; Kenichi Yasunari; K Nakagawa; T Hamada; Shuzo Otani; M Yanagisawa; Tadashi Takeda
Hypertension associated with endothelin-secreting malignant hemangioendothelioma.
Annals of internal medicine 1991;114(3):213-5.
1991: K Yokokawa; H Tahara; M Kohno; K Murakawa; Kenichi Yasunari; K Nakagawa; T Hamada; Shuzo Otani; M Yanagisawa; Tadashi Takeda
Endothelin-secreting tumor.
Journal of cardiovascular pharmacology 1991;17 Suppl 7():S398-401.
1990: K Yokokawa; K Murakawa; Kenichi Yasunari; M Kohno; T Inoue; Tadashi Takeda
Effect of propranolol on endothelin-induced increase in cytosolic free calcium.
American journal of hypertension 1990;3(12 Pt 1):936-8.
1990: Kenichi Yasunari; M Kohno; K Murakawa; K Yokokawa; Tadashi Takeda
Glucocorticoids and atrial natriuretic factor receptors on vascular smooth muscle.
Hypertension 1990;16(5):581-6.
1990: M Kohno; Kenichi Yasunari; K Yokokawa; K Murakawa; T Horio; Y Kanayama; M Fuzisawa; T Inoue; Tadashi Takeda
Thrombin stimulates the production of immunoreactive endothelin-1 in cultured human umbilical vein endothelial cells.
Metabolism: clinical and experimental 1990;39(10):1003-5.
1990: K Yokokawa; M Kohno; K Murakawa; Kenichi Yasunari; Tadashi Takeda
Effect of endothelin-1 on cytosolic calcium ions in cultured human endothelial cells.
Journal of hypertension 1990;8(9):843-9.
1990: M Kohno; Kenichi Yasunari; K Murakawa; K Yokokawa; T Horio; T Fukui; Tadashi Takeda
Release of immunoreactive endothelin from porcine aortic strips.
Hypertension 1990;15(6 Pt 2):718-23.
1990: M Kohno; Kenichi Yasunari; K Murakawa; K Yokokawa; T Horio; T Fukui; Tadashi Takeda
Plasma immunoreactive endothelin in essential hypertension.
The American journal of medicine 1990;88(6):614-8.
1990: M Kohno; K Murakawa; T Horio; N Kurihara; K Yokokawa; Kenichi Yasunari; T Fukui; Tadashi Takeda
Endothelin stimulates release of atrial natriuretic factor in anesthetized rats.
Metabolism: clinical and experimental 1990;39(6):557-9.
1990: K Murakawa; M Kohno; K Yokokawa; Kenichi Yasunari; N Kurihara; A Hyono; Tadashi Takeda
Endothelin does not affect intracellular calcium ion concentration in the platelets of rats.
American journal of hypertension 1990;3(4):307-9.
1990: M Kohno; Kenichi Yasunari; K Murakawa; K Yokokawa; T Horio; N Kurihara; Tadashi Takeda
Effect on atrial natriuretic peptides of chronic treatment with alpha-methyldopa and hydralazine in spontaneously hypertensive rats.
American journal of hypertension 1990;3(2):111-6.
1990: K Yokokawa; M Kohno; K Murakawa; Kenichi Yasunari; T Inoue; Tadashi Takeda
Effects of endothelin on blood pressure and renal hemodynamics in DOCA-salt hypertensive rats under conscious and unrestrained condition.
Clinical and experimental hypertension. Part A, Theory and practice 1990;12(6):1049-62.
1990: K Murakawa; M Kohno; K Yokokawa; Kenichi Yasunari; T Horio; N Kurihara; Tadashi Takeda
Endothelin-induced renal vasoconstriction and increase in cytosolic calcium in renal vascular smooth muscle cells.
Clinical and experimental hypertension. Part A, Theory and practice 1990;12(6):1037-48.
1989: M Kohno; K Murakawa; K Yokokawa; Kenichi Yasunari; T Horio; N Kurihara; Tadashi Takeda
Production of endothelin by cultured porcine endothelial cells: modulation by adrenaline.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S130-1.
1989: M Kohno; Kenichi Yasunari; K Murakawa; K Yokokawa; T Horio; N Kurihara; Tadashi Takeda
Effect of a new angiotensin converting enzyme inhibitor, cilazapril, on circulating atrial natriuretic factor during exercise in patients with essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S298-9.
1989: M Kohno; K Murakawa; Kenichi Yasunari; K Yokokawa; N Kurihara; Tadashi Takeda
Possible involvement of atrial natriuretic factor in the antihypertensive action of a high-calcium diet in spontaneously hypertensive and Wistar-Kyoto rats.
Metabolism: clinical and experimental 1989;38(10):997-1004.
1989: K Yokokawa; M Kohno; K Murakawa; Kenichi Yasunari; T Horio; T Inoue; Tadashi Takeda
Acute effects of endothelin on renal hemodynamics and blood pressure in anesthetized rats.
American journal of hypertension 1989;2(9):715-7.
1989: M Kohno; K Murakawa; Kenichi Yasunari; K Yokokawa; T Horio; N Kurihara; Tadashi Takeda
Prolonged blood pressure elevation after endothelin administration in bilaterally nephrectomized rats.
Metabolism: clinical and experimental 1989;38(8):712-3.
1989: Kenichi Yasunari; M Kohno; Anthony J Balmforth; K Murakawa; K Yokokawa; N Kurihara; Tadashi Takeda
Glucocorticoids and dopamine-1 receptors on vascular smooth muscle cells.
Hypertension 1989;13(6 Pt 1):575-81.
1989: K Murakawa; M Kohno; Kenichi Yasunari; K Yokokawa; N Kurihara; T Nagasawa; Y Kinoshita; Tadashi Takeda
Effect of salt-loading on erythrocyte deformability in spontaneously hypertensive and Wistar-Kyoto rats.
Life sciences 1989;45(12):1089-95.
1988: K Murakawa; M Kohno; Kenichi Yasunari; K Yokokawa; T Horio; Tadashi Takeda
Possible involvement of protein kinase C in the maintenance of hypertension in spontaneously hypertensive rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S157-9.
1988: M Kohno; Kenichi Yasunari; K Murakawa; K Yokokawa; Kaname Akioka; Masakazu Teragaki; M Yasuda; T Nishikimi; H Oku; Kazuhide Takeuchi
Physiological significance of atrial natriuretic peptides in essential hypertension.
Japanese circulation journal 1988;52(12):1465-7.
1988: Kenichi Yasunari; M Kohno; K Murakawa; K Yokokawa; Tadashi Takeda
Effect of glucocorticoid on prostaglandin E1 mediated cyclic AMP formation by vascular smooth muscle cells.
Journal of hypertension 1988;6(12):1023-8.
1988: M Kohno; K Murakawa; Kenichi Yasunari; K Yokokawa; N Kurihara; Tadashi Takeda
Effect of long-term treatment with diltiazem on atrial natriuretic peptides in spontaneously hypertensive rats.
Clinical and experimental hypertension. Part A, Theory and practice 1988;10(5):859-71.
1987: M Kohno; K Murakawa; Kenichi Yasunari; Yoshiki Nishizawa; Hirotoshi Morii; Tadashi Takeda
Circulating atrial natriuretic peptides in hyperthyroidism and hypothyroidism.
The American journal of medicine 1987;83(4):648-52.